Sofosbuvir; Velpatasvir; Voxilaprevir Patents

Given below is the list of patents protecting Sofosbuvir; Velpatasvir; Voxilaprevir, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Sofosbuvir; Velpatasvir; Voxilaprevir's patents.

Latest Legal Activities on Sofosbuvir; Velpatasvir; Voxilaprevir's Patents

Given below is the list recent legal activities going on the following patents of Sofosbuvir; Velpatasvir; Voxilaprevir.

Activity	Date	Patent Number
Legal Activities This Week
Payment of Maintenance Fee, 8th Year, Large Entity	13 Sep, 2023	US9296782
Payment of Maintenance Fee, 8th Year, Large Entity	03 Aug, 2022	US8957046
Post Issue Communication - Certificate of Correction	21 Jun, 2022	US11338007
Recordation of Patent Grant Mailed Critical	24 May, 2022	US11338007
Patent Issue Date Used in PTA Calculation Critical	24 May, 2022	US11338007
Email Notification Critical	05 May, 2022	US11338007
Issue Notification Mailed Critical	04 May, 2022	US11338007
Email Notification Critical	28 Apr, 2022	US11338007
Mailing Corrected Notice of Allowability	28 Apr, 2022	US11338007
Corrected Notice of Allowability	22 Apr, 2022	US11338007

Sofosbuvir; Velpatasvir; Voxilaprevir's Family Patents

Full family tree